Saxagliptin and Heart Failure in the SAVOR-TIMI 53 Trial: Reflections on the Bradford Hill Criteria

Rev Esp Cardiol (Engl Ed). 2017 Dec;70(12):1143-1144. doi: 10.1016/j.rec.2017.02.023. Epub 2017 Mar 9.
[Article in English, Spanish]
No abstract available

Publication types

  • Letter
  • Review

MeSH terms

  • Adamantane / analogs & derivatives*
  • Adamantane / therapeutic use
  • Causality
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Dipeptides / therapeutic use*
  • Dipeptidyl-Peptidase IV Inhibitors / therapeutic use*
  • Heart Failure*
  • Hospitalization / statistics & numerical data*
  • Humans
  • Proportional Hazards Models

Substances

  • Dipeptides
  • Dipeptidyl-Peptidase IV Inhibitors
  • saxagliptin
  • Adamantane